vimarsana.com

Page 57 - நாஸ்டாக் உலகளாவிய தேர்ந்தெடுக்கவும் சந்தை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Intapp Announces Pricing of Initial Public Offering

Intapp Announces Pricing of Initial Public Offering June 29, 2021 20:19 ET | Source: Intapp Inc. Intapp Inc. Palo Alto, California, UNITED STATES PALO ALTO, Calif., June 29, 2021 (GLOBE NEWSWIRE) Intapp, Inc., a leading provider of industry-specific, cloud-based software solutions that enable connected professional and financial services firms, today announced the pricing of its initial public offering of 10,500,000 shares of its common stock at a price to the public of $26.00 per share. In addition, the underwriters will have a 30-day option to purchase from Intapp up to an additional 1,575,000 shares of its common stock at the initial public offering price, less underwriting discounts and commissions.

CVRx, Inc Announces Upsized Pricing of Initial Public

CVRx, Inc. Announces Upsized Pricing of Initial Public Offering June 29, 2021 20:17 ET | Source: CVRx, Inc. CVRx, Inc. Minneapolis, UNITED STATES MINNEAPOLIS, June 29, 2021 (GLOBE NEWSWIRE) CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally invasive neuromodulation solutions for patients with cardiovascular diseases, announced today the upsize and pricing of its initial public offering of 7,000,000 shares of its common stock at a public offering price of $18.00 per share. In connection with the offering, CVRx has granted the underwriters a 30-day option to purchase up to an additional 1,050,000 shares of common stock at the initial public offering price, less the underwriting discount. The shares are expected to begin trading on the Nasdaq Global Select Market on June 30, 2021 under the ticker symbol “CVRX.” The gross proceed

ObsEva SA: ObsEva Presents Clinical Data on Open-Label Pilot Study of Yselty (linzagolix) for the Treatment of Severe Adenomyosis at ESHRE Virtual 37th Annual Meeting

ObsEva SA: ObsEva Presents Clinical Data on Open-Label Pilot Study of Yselty (linzagolix) for the Treatment of Severe Adenomyosis at ESHRE Virtual 37th Annual Meeting
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Clickbait provider Outbrain files for IPO

Quotes delayed at least 15 minutes. Real-time quotes provided by BATS BZX Real-Time Price. Market Data provided by Interactive Data (Terms & Conditions). Powered and Implemented by Interactive Data Managed Solutions. Company fundamental data provided by Morningstar. Earnings estimates data provided by Zacks. Mutual fund and ETF data provided by Lipper. Economic data provided by Econoday. Dow Jones & Company Terms & Conditions. This material may not be published, broadcast, rewritten, or redistributed. ©2021 FOX News Network, LLC. All rights reserved. FAQ - Updated Privacy Policy

LegalZoom Announces Pricing of Initial Public Offering

Share: LegalZoom.com, Inc. ( LegalZoom ), today announced the pricing of its initial public offering of an aggregate of 19,121,000 shares of common stock at a price to the public of $28.00 per share. In addition, LegalZoom has granted the underwriters a 30-day option to purchase up to an additional 2,868,150 shares of its common stock at the public offering price, less underwriting discounts and commissions. The shares are expected to begin trading on the Nasdaq Global Select Market on June 30, 2021 under the symbol LZ and the offering is expected to close on July 2, 2021, subject to customary closing conditions. J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Barclays Capital Inc. are acting as lead book-running managers for the proposed offering. BofA Securities, Inc., Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC and Jefferies LLC are acting as book-running managers for the proposed offering. JMP Securities LLC, Raymond James & Associates, Inc., W

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.